Introduction
============

Chloride is the major strong anion in blood - accounting for approximately one-third of plasma tonicity, for 97 to 98% of all strong anionic charges and for two-thirds of all negative charges in plasma \[[@B1]\]. The amount of attention chloride receives in critically ill patients, however, is limited and much less than other routinely measured electrolytes. For example, the PubMed search term \'hyperchloremia\' generates 181 citations while \'hypernatremia\' and \'hypercalcemia\' generate 2,481 and 15,518 citations, respectively \[[@B2]\]. It is therefore little surprise that chloride is sometimes referred to as the forgotten electrolyte \[[@B3]\].

Progress in our understanding of acid-base and chloride channel physiology, however, challenges the notion that neglecting chloride is justified. This progress can be traced to more than 100 years ago with the observation of a poisonous effect of sodium chloride solutions on nerve muscle preparation \[[@B4]\], followed by recognition of metabolic acidosis after saline infusion in the 1920s \[[@B5]\], and the concept of hyperchloraemic acidosis \[[@B6],[@B7]\]. In the 1990s, hyperchloraemic acidosis became more thoroughly studied \[[@B8]-[@B15]\] as the physicochemical approach (Stewart approach) to acid-base analysis \[[@B16],[@B17]\] began to receive wider acceptance. Within the Stewart approach, chloride is the dominant negative strong ion in plasma and a key contributor to the strong ion difference (SID), one of the three independent variables that determine the hydrogen ion concentration. Hyperchloraemia was thus finally seen as important for the pathogenesis of metabolic acidosis. This change in perception may be particularly relevant to intensivists, given that hyperchloraemia appears relatively common in intensive care unit (ICU) patients \[[@B18]\]. At the same time, our knowledge of chloride channels has increased in the past decade with new discoveries of their crystal structures, physiological roles and their association with human diseases \[[@B19]-[@B21]\].

All of these changes in attitude and knowledge support the argument that the role of chloride in the ICU deserves more attention. In the present review, therefore, we wish to focus on the following five aspects: the fundamentals of chloride distribution and measurement, an outline of Stewart\'s physicochemical approach and the significance of chloride as a strong ion, chloride\'s roles through review of its channels and chloride regulation by the gut and kidney, chloride manipulation in the ICU and potential effects of disorders of chloraemia in the critically ill, and the implications of all the above on current critical care practice and research.

Chloride distribution and measurement
=====================================

The main source of chloride is dietary sodium chloride, intake of which is 7.8 to 11.8 g/day for adult men and 5.8 to 7.8 g/day for adult women in the United States \[[@B22]\] - equivalent to 133 to 202 mmol and 99 to 133 mmol chloride, respectively (chloride molar mass, 35.5 g/mol). This intake approximates to administration of 0.5 to 1.3 litres per day of 0.9% saline (chloride, 154 mmol/l).

The chloride distribution in the three major body fluid compartments - plasma, interstitial fluid (ISF) and intracellular fluid - is shown in Figure [1](#F1){ref-type="fig"}. Chloride is the most abundant anion in plasma and ISF, the two compartments that make up extracellular fluid. Its concentrations in these two compartments differ slightly as a result of capillary impermeability to proteins, especially albumin. The asymmetric distribution of anionic proteins between plasma and ISF results in the Gibbs-Donnan effect, with the ISF chloride concentration 5 to 10% greater than in plasma \[[@B23]\]. Most cells have intracellular concentrations of about 10 mmol/l \[[@B23]\], but the range varies widely from 2 mmol/l in skeletal muscle to 90 mmol/l in erythrocytes \[[@B24]\].

![**Chloride distribution in the major body fluid compartments**.](cc9052-1){#F1}

It is important for clinicians to recognize that the measured plasma chloride concentration may differ between assays. With paired samples, the mean difference (bias) in plasma chloride concentration between central laboratory and point-of-care assays can be 1.0 mmol/l (95% limits of agreement, -6.4 to 4.6 mmol/l) \[[@B25]\]. While decreased plasma albumin contributes to differences in sodium assays, however, albumin changes have little effect on chloride assays \[[@B26]\]. Further, while the reference range for central laboratory assays is often quoted as 97 to 107 mmol/l, some machines used in central laboratories have a reference range of 100 to 110 mmol/l. Using paired samples (unpublished results), when our central laboratory changed from a Hitachi to a Beckman machine, we found a bias in plasma chloride of 2.0 mmol/l (95% limits of agreement, -1.7 to 5.6 mmol/l). While these differences are important in assessing chloride alone, they will also affect derived variables including the anion gap \[[@B26]\], the corrected anion gap \[[@B27]\], the strong ion gap \[[@B28]\], and the sodium chloride difference \[[@B29]\].

Chloride and the Stewart approach
=================================

The surge in the number of studies on hyperchloraemic acidosis coincided with the emergence of the Stewart physicochemical approach, with many comparisons of 0.9% saline and colloids suspended in saline solutions with more balanced, lower chloride, intravenous solutions (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}). Compared with lactated Ringer\'s solution in patients undergoing major gynaecological surgery, infusion of 30 ml/kg/hour of 0.9% saline caused a significant acidosis within 2 hours \[[@B9]\]. This finding, coupled with higher chloride measurement in the saline group, was replicated in a number of other studies \[[@B10],[@B12],[@B14],[@B15],[@B30]\]. Significant negative correlation between hyperchloraemia and base excess was further shown in patients undergoing surgery for more than 4 hours \[[@B10]\] and in an audit of ICU patients \[[@B18]\].

###### 

Electrolyte composition of commonly used crystalloids

                Concentration (mmol/l)                     
  ------------- ------------------------ ----- ----- ----- -----
  Sodium        140                      154   131   140   140
  Potassium     5                        0     5     5     4
  Chloride      100                      154   111   98    127
  Calcium       2.2                      0     2     0     2.5
  Magnesium     1                        0     1     1.5   1
  Bicarbonate   24                       0     0     0     0
  Lactate       1                        0     29    0     0
  Acetate       0                        0     0     27    24
  Gluconate     0                        0     0     23    0
  Maleate       0                        0     0     0     5

Plasma-Lyte 148^®^from Baxter International (Deer field, IL, USA). Sterofundin^®^from B Braun (Melsungen, Germany).

###### 

Electrolyte composition of commonly used colloids

                Concentration (mmol/l)                           
  ------------- ------------------------ ----- ----- ----- ----- -----
  Sodium        140                      154   140   154   143   140
  Potassium     5                        0     0     0     3     4.0
  Chloride      100                      125   128   154   124   118
  Calcium       2.2                      0     0     0     2.5   2.5
  Magnesium     1                        0     0     0     0.5   1.0
  Bicarbonate   24                       0     0     0     0     0
  Lactate       1                        0     0     0     28    0
  Acetate       0                        0     0     0     0     24
  Malate        0                        0     0     0     0     5
  Octanoate     0                        0     6.4   0     0     0

HES, hydroxyethyl starch. Gelofusine^®^, Venofundin^®^and Tetraspan^®^from B Braun (Melsungen, Germany). Albumex^®^4 from CSL Limited (Broadmeadows, Victoria, Australia). Voluven^®^from Fresenius-Kabi (Bad Homburg, Germany). Hextend^®^from BioTime Inc. (Berkeley, CA, USA).

An understanding of Stewart\'s approach may help to understand how chloride might affect the hydrogen ion concentration \[H^+^\] \[[@B16],[@B17]\]. Through quantitative analysis that satisfies the principles of electroneutrality, dissociation equilibria and conservation of mass, this approach argues that determination of \[H^+^\] depends on three independent variables: the SID, the partial pressure of carbon dioxide, and the total weak acid concentration. A change in any of these three variables, and not in bicarbonate, will change the acid-base balance. Bicarbonate becomes a marker and not a mechanism, a major difference between the Stewart approach and the traditional Henderson-Hasselbalch approach.

In the traditional approach, bicarbonate independently determines pH as reflected by the Henderson-Hasselbalch equation:

Under the Stewart approach, however, bicarbonate is just one of the various dependent ions. Whether the Stewart approach more truly reflects the biochemical events at work during acid-base disorders remains controversial. However, its practical utility has been repeatedly shown \[[@B11],[@B31]\].

Together with other completely dissociated strong ions, chloride determines the SID:

Quantitatively, a change in the strong ion composition leading to lower SID will increase \[H^+^\] while an increase in SID will decrease \[H^+^\]. Hyperchloraemic acidosis therefore causes acidosis by decreasing SID and not through hyperchloraemia alone. This notion is supported by data demonstrating a stronger association between SID and bicarbonate than that between chloride and bicarbonate \[[@B31]\].

Hyperchloraemic acidosis is now increasingly described in terms of its SID nature, including the contribution of the strong ion gap or unmeasured anions \[[@B32],[@B33]\]. A detailed explanation of these concepts is beyond the scope of the present review.

At the other end of the spectrum, alkalosis may thus occur with both hypochloraemia and hyperchloraemia, with the latter occurring in the presence of greater hypernatraemia (greater SID) \[[@B34]\]. This again highlights the importance of relative rather than absolute chloraemia. In a study of patients with chronic obstructive pulmonary disease, subjects were found to have hypochloraemia without significant changes in plasma sodium, resulting in a higher SID and subsequent alkalosis \[[@B35]\]. This interestingly concurs with an animal study showing increased renal chloride excretion during hypochloraemia of respiratory acidosis \[[@B36]\].

Chloride channels
=================

For years, knowledge of chloride channels lagged behind the better known sodium, potassium and calcium channels \[[@B19]\]. Several milestones in the field of ion channels - such as cloning of the cystic fibrosis transmembrane regulator in 1989, cloning of the first voltage-gated chloride channel in 1990 and, more recently, discovery of the crystal structure of chloride channels \[[@B19]-[@B21]\] - have altered this scenario. These anion channels are no longer merely unimportant leaks associated with cation channels in the excitable cells \[[@B37]\].

Examples of the different subtypes of these channels, categorised based on their different regulations and roles, are presented in Table [3](#T3){ref-type="table"}. Of these subtypes, the cystic fibrosis transmembrane conductance regulator and the ligand-gated chloride channels, activated by GABA~A~and glycine, are probably best known to ICU clinicians. The other subtypes are, nevertheless, no less important. Voltage-gated chloride channels come from nine different genes with a unique dimeric, double-pore (double-barrelled) structure \[[@B20],[@B21]\]. The structure discovery and further exploration of their molecular mechanisms are seen as frontiers towards greater application of chloride channel manipulation in medicine. Recent insights into these voltage-gated chloride channels have already showed their significant neurological \[[@B38],[@B39]\] and gastrointestinal \[[@B40]\] connections. Calcium-activated chloride channels, on the other hand, are found in various cell types, including epithelial cells, neurons, cardiac cells, smooth muscles and blood cells \[[@B21]\]. They are activated by cytoplasmic calcium elevation following a wide range of stimuli, which include cholinergic activation of glandular secretory epithelium and pain in the dorsal root ganglia neurons \[[@B37]\]. Finally, volume-sensitive chloride channels are an essential element of cell volume regulation. Exposure to hypotonic media stimulates chloride ion efflux through these channels, leading to equilibrium with extracellular tonicity; restoring the cell volume in the process \[[@B21]\]. This cell-volume decrease is now believed to have a role in apoptotic cell death \[[@B41]\], a phenomenon of interest in sepsis \[[@B42]\].

###### 

Examples of chloride channels

  Channel                               Mechanism of regulation                Physiological role
  ------------------------------------- -------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------
  CFTR channels                         Cyclic AMP-dependent phosphorylation   Cl^-^secretion in airways, submucosal glands, pancreas, intestine and testis; Cl^-^absorption in sweat glands
  CIC-1 channels                        Depolarization                         Cl^-^conductance in skeletal muscle; repolarization after action potential
  CIC-2 channels                        Hyperpolarization and cell swelling    Cl^-^homeostasis in neurons
  Calcium-activated chloride channels   Cystosolic Ca^2+^                      Cl^-^transport in retinal pigment epithelium; Cl^-^secretion in epithelia, neurons, cardiac muscles and erythrocytes; smooth muscle contraction
  GABA~A~channels                       GABA~A~                                Inhibition of synaptic transmission in the brain
  Glycine channels                      Glycine, β-alanine and taurine         Inhibition of synaptic transmission in the spinal cord
  Volume-sensitive chloride channels    Cell volume changes                    Restoration of cell volume

CFTR, cystic fibrosis transmembrane conductance regulator; CIC, voltage-gated chloride channel; GABA, γ-aminobutyric acid.

Chloride regulation by the gut and kidney
=========================================

Gastrointestinal secretions are rich in chloride, with gastric secretions the predominant source. In the stomach, chloride secreted by apical chloride channels in parietal cells will match hydrogen ions released by the H^+^/K^+^-ATPase antiporter pumps (proton pumps), forming hydrochloric acid. Basal output of this acid is in the range 0 to 11 mmol/hour, increasing to 10 to 63 mmol/hour with meals \[[@B43]\]. This load of acid, and thus chloride, is regulated by synergistic activities of histamine, gastrin and acetylcholine.

Chloride is also the main electrolyte driving fluid secretion throughout the intestinal epithelium. Paracellular movement of sodium that accompanies transepithelial chloride secretion results in luminal sodium chloride, which forms the osmotic pressure for water movement with secretions of 8 l/day \[[@B44]\], which are largely reabsorbed throughout the intestinal tract.

Chloride is primarily excreted by the kidney. An average of 19,440 mmol is filtered through the kidneys every day, with 99.1% being reabsorbed, leaving only 180 mmol excreted per day \[[@B45]\]. Most of the reabsorption occurs in the proximal tubule, by passive reabsorption, ion conductance or active coupled transport with other ions \[[@B46]\]. Chloride reabsorption involves members of the solute carrier (SLC) gene families SLC26 and SLC24. These two gene families are expressed in various parts of the kidney, particularly in key components of renal acid-base regulation; that is, renal proximal tubules and intercalated cells of distal nephron. The intercalated cells are further differentiated into type A (alpha) cells that excrete protons and type B (beta) cells that secrete bicarbonate and reabsorb chloride \[[@B47]\]. The transport activities of the two SLC families underline the role of chloride in renal acid-base regulation.

The SLC26 family are primarily chloride-anion exchangers; exchanging sulphate, iodide, formate, oxalate, hydroxyl ion and bicarbonate anions \[[@B47]\]. They include SLC26A6 in the proximal tubule that mediates apical chloride-anion exchange, and SLC26A4 (pendrin) in the distal nephron that mediates chloride-anion exchange across the luminal membrane of type B intercalated cells.

The SLC4 solute carriers, on the other hand, predominantly function as chloride-bicarbonate and anion exchangers and sodium-bicarbonate co-transporters (NBC). Examples are SLC4A1 (also known as AE1), which mediates chloride-bicarbonate exchange in the basolateral membrane of type A intercalated cells (exchange of chloride into intercalated cells and bicarbonate into plasma), and SLC4A4 (also known as NBC1), which mediates sodium-bicarbonate co-transport in renal proximal tubule cells \[[@B46],[@B48]\].

These renal chloride carriers are key components of suggested models for physicochemical renal acid-base regulation \[[@B46]\]. Figure [2](#F2){ref-type="fig"} shows an example of such regulation across proximal tubule cells. Physicochemical modelling of distal renal tubular acidosis from mutation of SLC4A1 (AE1) and proximal renal tubular acidosis from mutation of SLC4A4 (NBC1) \[[@B49]\] has also consolidated the argument for the Stewart approach. This renal tubular acidosis modelling focuses on renal net handling of Na^+^, K^+^and Cl^-^, the SID constituents, which means that chloride movement is no longer secondary to bicarbonate changes. In another physicochemical viewpoint, a departure from the conventional explanation of ammonium ion NH~4~^+^as a carrier of H^+^has been proposed \[[@B50]\]. NH~4~^+^should instead be seen as a weak cation that, by co-excretion with chloride, allows loss of chloride without sodium or potassium.

![**Integration of proximal convoluted tubule chloride transport mechanisms with strong ion difference and partial pressure**. Chloride is reabsorbed from passive paracellular transport, conductance and active coupled transport at both apical and basolateral membranes. The strong ion difference (SID) in the plasma, together with the partial pressure of carbon dioxide (PCO~2~), regulates these transport activities and determines the hydrogen ion concentration. KCC, K^+^Cl^-^co-transporter; NHE, Na^+^H^+^exchanger; SLC26A6, solute carrier 26A6; SLC4A4, solute carrier 4A4.](cc9052-2){#F2}

Disorders of chloraemia and manipulation of chloride in the ICU
===============================================================

Hyperchloraemia or hypochloraemia, resulting from disease processes or clinical manipulations, is common in the ICU (see Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}), and should always be seen in relation to sodium. Hyperchloraemia with hypernatraemia, or hypochloraemia with hyponatraemia, will not change the SID and thus will not affect the acid-base balance.

###### 

Conditions associated with hypochloraemia in the intensive care unit

  --------------------------------------------
  Chloride loss
   Diuretic therapy
   Significant gastric drainage
   Vomiting
   Chronic respiratory acidosis
  Water gain in excess of chloride
   Congestive cardiac failure
   Syndrome of inappropriate ADH secretion
   Excessive infusion of hypotonic solutions
  --------------------------------------------

###### 

Conditions associated with hyperchloraemia in the intensive care unit

  ----------------------------------------------------------------
  Chloride infusion
   Administration of chloride-rich fluids
   Total parenteral nutrition
  Pure water loss
   Skin losses
   Fever
   Hypermetabolic states
   Renal losses
   Central diabetes insipidus
   Nephrogenic diabetes insipidus
  Water loss in excess of chloride loss
   Extrarenal loss
   Diarrhoea
   Burns
   Renal loss
   Osmotic diuresis
   Post-obstructive diuresis
   Intrinsic renal disease
  Definite or relative increase in tubular chloride reabsorption
   Renal tubular acidosis
   Recovery of diabetic ketoacidosis
   Early renal failure
   Acetazolamide
   Ureteral diversion procedures
   Post hypocapnia
  ----------------------------------------------------------------

Intravenous administration of chloride-rich fluids is probably the most common and modifiable cause of hyperchloraemia in the ICU. The chloride content of these fluids, from 0.9% NaCl (saline) to the various colloids suspended in saline (Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}), is supra-physiologic \[[@B51]\], with significant hyperchloraemia following the administration of such fluids in volunteers \[[@B13],[@B52]\], intraoperatively \[[@B9],[@B10],[@B12],[@B14],[@B15],[@B30]\] or as cardiopulmonary bypass prime fluid \[[@B11]\].

While saline was a life-saving measure when first introduced during the cholera pandemic of Europe in the 1830s \[[@B53]\], it is to be noted that the saline used then was of a different composition. A reconstitution of the Thomas Latta solution revealed a sodium concentration of 134 mmol/l, chloride 118 mmol/l and bicarbonate 16 mmol/l. The historical or scientific basis of the present-day 0.9% composition of saline remains a mystery, even when traced to those cholera pandemic days that marked the beginning of the intravenous fluid technique and its various solutions \[[@B54]\]. On the other hand, there appears to be common lack of basic knowledge for optimal fluid and electrolyte prescription. Intravenous fluid and electrolyte prescriptions in postoperative surgical patients vary widely, with 0.9% saline being most common, and show poor correlation between serum electrolyte values and the amounts of electrolytes prescribed \[[@B55]\]. Moreover, less than one-half of prescribers in 25 different surgical units were aware of the sodium content of 0.9% saline \[[@B56]\]. Chloride-rich fluids result in acidosis and evidence from animal studies, particularly in sepsis, point to a possible association with negative outcomes.

Chloride and resuscitation of sepsis
====================================

Fluid resuscitation is a mainstay for the treatment of severe sepsis. The recognition of hyperchloraemic strong ion acidosis has led to the reconsideration of the impact of intravenous fluid contents in septic patients.

In anaesthetized dogs infused with endotoxin, high chloride saline infusion given to maintain mean arterial pressure \>80 mmHg increased serum chloride and accounted for 42% of the total acid load \[[@B57]\], significantly greater than the contribution by lactate. When comparing saline resuscitation with Hextend^®^(hydroxyethyl starch (HES) in balanced solution; BioTime Inc., Berkeley, CA, USA) in a rat model of septic shock, investigators reported significantly lower standard base excess and SID and a lower mean survival time with saline \[[@B58]\].

In an animal study of the effects of hyperchloraemic acidosis from saline, the degree of systemic hypotension correlated significantly with the increase in plasma chloride levels \[[@B59]\], a stronger correlation than with pH. A significant increase was also seen in plasma nitrite levels in the saline group; in cell cultures, however, hyperchloraemic acidosis was found to be proinflammatory, inducing nitric oxide release, increased IL-6:IL-10 ratios and increased NF-κB DNA binding \[[@B60]\]. In a second animal study, after controlling for hypotension, there was a significant increase in cytokines with hyperchloraemic acidosis - greater increases were seen with more severe acidosis \[[@B61]\].

Therefore it would seem prudent to avoid chloride-rich fluids in sepsis despite controversy on whether acidosis results in physiological injury or is just a side effect of illness \[[@B62]\]. At present, the best evidence for acidosis-induced organ injury is mainly from animal studies \[[@B63],[@B64]\] - thus making any specific recommendation difficult.

Hyperchloraemia and renal function
==================================

Animal studies offer insight into the role of chloride in regulating renal blood flow. In denervated dog kidneys, intrarenal infusion of chloride-containing solutions produced renal vasoconstriction and a fall in the glomerular filtration rate \[[@B65]\]. This observation was specific for renal vessels, and the investigators proposed tubular chloride reabsorption as a key initiating step, based on similarities with the tubuloglomerular feedback mechanism, also initiated by chloride reabsorption \[[@B66]\]. This tubuloglomerular feedback is a regulation of the glomerular filtration rate, which begins with chloride detection at the macula densa and ends with mesangial contraction reducing the glomerular filtration rate. Increased chloride re-absorption through a Na/K/2Cl transporter activates the release of ATP for mesangial contraction \[[@B67]\]. In another animal study, the same group found that thromboxane may mediate chloride-induced vasoconstriction \[[@B68]\]. Another possible explanation for the phenomenon of hyperchloraemic renal vasoconstriction is the effect of chloride on renal responsiveness to vasoconstrictor agents. A study of the isolated rat kidney showed that continuous perfusion with high chloride progressively increased renal vascular responsiveness to angiotensin II \[[@B69]\]. A more comprehensive understanding of the vasoconstriction mechanisms, including probable interaction between chloride and other ions like calcium, could be on the horizon given the recent progress in chloride channels mentioned earlier.

Studies on human volunteers and patients support the above observations. A longer time to first micturition was observed with saline compared with a lactated solution in a crossover trial with human volunteers \[[@B70]\]. This observation was replicated in another human volunteer study, also with greater diuresis and natriuresis in the lactated solution group \[[@B52]\]. While the shorter time to micturition and greater diuresis could be attributed to the lower osmolality of the lactated solution causing decreased antidiuretic hormone secretion, the greater natriuresis suggests a specific chloride effect on the glomerular filtration rate.

Of further interest to ICU practice is the comparison of high-chloride fluids and low-chloride fluids during surgery. In older patients undergoing major surgery, a lower chloride load from a lactated solution or 6% hetastarch in balanced solution (Hextend^®^) again led to greater urine output compared with 0.9% saline and with 6% hetastarch in 0.9% saline \[[@B14]\]. A comparable study in older cardiac surgery patients revealed that the lower chloride group treated with balanced 6% HES 130/0.42 plus a balanced crystalloid solution had significantly lower urinary concentrations of kidney-specific markers of injury - namely glutathione transferase alpha and neutrophil gelatinase-associated lipocalin - when measured up to the second postoperative day in the ICU \[[@B71]\].

In patients with renal dysfunction, many believe the risk of hyperkalaemia is greater with potassium-containing fluids like lactated solutions, thus leading to significantly higher use of 0.9% saline \[[@B72]\]. In contradiction to this paradigm, a randomized double-blind trial comparing lactated Ringer\'s solution and 0.9% saline during renal transplantation revealed a higher incidence of hyperkalaemia in the 0.9% saline group instead of in the lactated Ringer\'s solution group. The incidence of metabolic acidosis was also higher in the 0.9% saline group \[[@B73]\]. The authors suggested that hyperkalaemia was secondary to extracellular potassium shift due to hyperchloraemic (low-SID) acidosis.

Chloride and splanchnic perfusion
=================================

The above crossover trial comparing 0.9% saline with the lactated Ringer\'s solution in human volunteers also found a higher incidence of abdominal discomfort with saline \[[@B70]\]. This raised questions about splanchnic perfusion. In a study of older patients undergoing major surgery, the saline group had a higher postoperative gastric tonometric carbon dioxide gap, suggesting reduced gastric mucosal perfusion \[[@B14]\]. This study, although not powered to show a difference, also showed a significant trend towards increased nausea and vomiting in the saline group. While chloride\'s link to this phenomenon is unclear, it is interesting to note that a report of ammonium chloride poisoning referred to similar signs of nausea, vomiting and abdominal pain \[[@B74]\]. Animal studies, meanwhile, have demonstrated acidosis-induced intestinal injury \[[@B64]\] and impaired gastric-pyloric motility \[[@B75]\]. These findings warrant further investigation to define the role of chloride in the modulation of splanchnic perfusion.

Chloride and haemostasis
========================

In a swine model of massive haemorrhage \[[@B76]\] comparing resuscitation with 0.9% saline, Ringer\'s lactate, Plasmalyte A and Plasmalyte R, investigators found that - apart from a significant decrease in acidosis with Ringer\'s lactate, Plasmalyte A and Plasmalyte R - Ringer\'s lactate also achieved a trend towards a higher survival rate. A decade later, in a rat model of massive haemorrhage, resuscitation with red blood cells and Ringer\'s lactate solution produced a significantly better acid-base balance and significantly greater 2-week survival than resuscitation with red blood cells and 0.9% saline \[[@B77]\]. The hyperchloraemic acidosis seen with 0.9% saline resuscitation has also been highlighted as an easily preventable iatrogenic cause of acidosis in trauma resuscitation \[[@B78]\].

Hyperchloraemic acidosis has also been suggested as part of the explanation for increased blood loss, increased requirement for blood and blood products, and coagulation abnormalities in patients receiving 0.9% saline or HES suspended in saline \[[@B15],[@B79],[@B80]\]. In a randomized trial comparing Hextend^®^(a 6% HES in a balanced solution) with 6% HES in saline, trends toward less bleeding were seen in the Hextend^®^group. The HES in saline group further showed significant prolongation of time to onset of clot formation on thromboelastography, an effect not seen in the Hextend^®^group \[[@B79]\]. Another randomized trial comparing 0.9% saline against lactated Ringer\'s solution for patients undergoing abdominal aortic aneurysm demonstrated a similar pattern. The saline group received significantly more blood products and had a trend towards increased blood loss \[[@B15]\]. In another comparison of 6% HES in balanced vehicle against 6% HES in saline during major surgery, a hypo-coagulable state (confirmed by significantly abnormal thromboelastography) was seen in HES in saline \[[@B80]\]. Apart from its high chloride concentration, the lack of calcium in saline is another explanation for saline\'s worse haemostatic profile as shown in these trials.

There have also been a number of experimental studies on healthy volunteers predominantly looking at the difference between HES in saline and HES in balanced solutions \[[@B81]-[@B83]\]. All studies used thromboelastography to assess coagulation, and one study used whole blood aggregometry to assess platelet function. A similar trend toward hypocoagulation with HES in saline was seen. Haemodilution with HES in saline also resulted in reduced aggregometry. While HES itself is known to affect coagulation and thromboelastography, recent changes to its physicochemical characteristics, especially molar substitution, has minimized this effect. The solvent and its electrolyte composition might thus have contributed to hypocoagulability.

Chloride in the ICU: the research agenda
========================================

The growing body of knowledge presented above highlights the need to re-evaluate our perception of chloride in critical care. Clinically, there is a need to reevaluate our intravenous fluid practice, the patients\' main source of external chloride. The evidence that the choice of fluids will affect the acid-base balance and could cause a host of other potentially undesirable physiological alterations, as described above, is difficult to ignore.

More importantly, all of this preliminary evidence leads to a number of research questions that are pertinent to chloride and the care of ICU patients. How common is hyperchloraemia in the ICU? Is hyperchloraemia an independent predictor of death or other adverse outcomes? Or does hyperchloraemia only matter when associated with SID changes or acidaemia? Can the elimination of chloride-rich fluids lead to clinical benefits? We consider these to be questions that need urgent attention given the millions of litres of saline and the millions of millimoles of excess chloride administered to patients worldwide every day.

Conclusions
===========

Chloride has been forgotten for too long. Better knowledge of its molecular functions, driven by new findings of the structure, molecular biology and physiology of its channels, and better understanding of the clinical effects of chloride loading, indicate that alterations in the chloride balance and chloraemia, both absolute and relative to natraemia, can alter the acid-base status, cell biology, renal function and haemostasis. The clinical consequences of these biological and physiological alterations remain unclear. The observation that most of these alterations appear to have negative implications and the knowledge that high-chloride fluids are administered to large numbers of patients worldwide, however, suggest the need to conduct formal investigations into the epidemiology and outcome implications of disorders of chloride balance and chloride concentration.
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